EVERSANA is a leading life sciences services company that advances commercialization and patient access to pharmaceuticals, biotech, and medical devices worldwide. Their mission is to accelerate patient access to treatments through innovative and integrated commercial models, patient-led care, and support services.

EVERSANA offers a comprehensive range of solutions including commercial services, integrated commercial services, patient services, market access strategies, pricing and revenue management, medical affairs, agency solutions, trade, channel and 3PL services, as well as data and analytics capabilities. They are known for leveraging AI to transform life sciences commercialization and have global capabilities with over 25 locations worldwide.

Deep therapeutic expertise is provided in various domains such as oncology, neurology & CNS, rare/orphan drugs, cell & gene therapies, and digital medicines.

The company emphasizes a patient-centered approach and best-in-class tailored services to meet the unique needs of pharmaceutical companies large and small. It supports launch readiness and complete commercialization, trusted by more than 20 emerging companies.

EVERSANA also features a dynamic leadership team and is recognized for innovation and excellence in pharma commercialization and prescription drug access.